- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 28, 2025 | 46.71M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $1.02B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $570.12M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $8.56B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $7.94B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $9.39B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $8.73B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 53.33M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $50.36M |
| Capex | Q1 2025 · Mar 31, 2024 | $1.6M |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | $75.42M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $816.77M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $807.28M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $1.06 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $1.07 |
| Net Income | Q1 2025 · Mar 31, 2024 | $56.43M |